← Back
$SPRY All transactions

ARS Pharmaceuticals, Inc.

▼ SELL 10b5-1 Plan

$ Value

$240K

Shares

15,000

Price

$16

Filed

Jun 20

Insider

Name

Karas Eric

Title

Chief Commercial Officer

CIK

0001951287

Roles

Officer

Transaction Details

Transaction Date

2025-06-18

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

7,696

Footnotes

The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 26, 2024. | Immediately exercisable.

Filing Info

Accession No.

0001415889-25-017901

Form Type

4

Issuer CIK

0001671858

Karas Eric's History

Date Ticker Type Value
2025-07-01 SPRY M $22K
2025-07-01 SPRY $255K
2025-07-01 SPRY M $0
2025-06-18 SPRY M $22K
2025-06-18 SPRY $240K
2025-06-18 SPRY M $0

Other Insiders at SPRY (90d)

No other insider activity at this issuer in the last 90 days.